Ferotein-S Iv SpecificationRequires Prescription (YES/NO)YesGenericsIron sucroseUsed ForFluids & ElectrolytesHow it worksIron sucrose injection is in a class of medications called iron replacement products. It works?by replenishing iron stores?so that the body can make more red blood cells.Ferotein-S Iv Usage And SafetyDosageIron sucroseSide EffectsCommon: transient taste perversions (in particular metallic taste). Uncommon: headache, dizziness, hypotension and collapse, tachycardia, palpitations, bronchospasm, dyspnea, nausea, vomiting, abdominal pain, diarrhea pruritus, urticaria, rash, exanthema, erythema, muscle cramps, myalgia, fever, shivering, flushing, chest pain and tightness. Injection site disorders such as superficial phlebitis, burning, swelling. Rare: paresthesia, anaphylactoid reactions (rarely involving arthralgia), peripheral edema, fatigue, asthenia, malaise. Isolated cases: reduced level of consciousness, light-headed feeling, confusion, angioedema, swelling of joints, hyperhidrosis and back pain. Hemodialyis dependent-chronic kidney disease (HDD-CKD) patients: hypotension, muscle cramps, nausea, headache, graft complications, vomiting, dizziness, hypertension, chest pain and diarrhea. Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients: dysgeusia, peripheral edema, diarrhea, constipation, nausea, dizziness and hypertension . Patients receiving erythropoietin may experience: diarrhea, edema, nausea, vomiting, arthralgia, back pain, headache, hypertension, dysgeusia, dizziness, extremity pain and injection site burning. Peritoneal dialysis dependent-chronic kidney disease (PDD-CKD) patients: diarrhea, peritoneal infection, vomiting, hypertension, pharyngitis, peripheral edema and nausea.Drug InteractionsAs with all parenteral iron preparations, iron sucrose should not be administered concomitantly with oral iron preparations since the absorption of oral iron is reduced. Therefore, oral iron therapy should be started at least 5 days after the last injection of Iron Sucrose.IndicationIron sucrose is indicated for the treatment of iron deficiency in the following: - Where there is a clinical need to deliver iron rapidly to iron stores. - Patients who cannot tolerate oral iron therapy or who are noncompliant. - In active inflammatory bowel disease where oral iron preparations are ineffective. - Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients receiving an erythropoietin. - Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients not receiving an erythropoietin. - Hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin. - Peritoneal dialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietinWhen not to UseThe use of iron sucrose is contra-indicated in cases of: - Known hypersensitivity to iron sucrose or any of its components. - Anemias not attributable to iron deficiency. - Iron overload or disturbances in utilization of iron. - Patients with a history of asthma, eczema or other atopic allergy, because they are more susceptible to experience allergic reactions. - Pregnancy first trimester .Ferotein-S Iv PrecautionsPrecautionParenteral administered iron preparations can cause allergic or anaphylactoid reactions, which may be potentially fatal. Therefore, treatment for serious allergic reactions and facilities with the established cardio-pulmonary resuscitation procedures should be available.Ferotein-S Iv WarningsWarning 1In patients with liver dysfunction, parenteral iron should only be administered after careful risk/benefit assessment. Parenteral iron administration should be avoided in patients with hepatic dysfunction where iron overload is a precipitating factor, in particular Porphyria Cutanea Tarda (PCT). Careful monitoring of iron status is recommended to avoid iron overload . Warning 2Parenteral iron must be used with caution in case of acute or chronic infection. It is recommended that the administration of iron sucrose is stopped in patients with ongoing bacteremia. In patients with chronic infection a risk/benefit evaluation has to be performed, taking into account the suppression of erythropoiesis . Warning 3Hypotensive episodes may occur if the injection is administered too rapidly. Allergic reactions, sometimes involving arthralgia, have been more commonly observed when the recommended dose is exceeded . Ferotein-S Iv Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
₦16,625.00
REFLORA Z SACH ₦763.25
REJUN 50MG TABLET ₦2,036.50
SkinCeuticals Brightening UV Defense SPF30 30ml ₦101,072.60
Ferosoft-S Iv SpecificationRequires Prescription (YES/NO)YesGenericsFerric sucrose complexUsed ForFluids & ElectrolytesHow it worksFerric sucrose injection is in a class of medications called iron replacement products. It works?by replenishing iron stores?so that the body can make more red blood cells.Ferosoft-S Iv Usage And SafetyDosageFerric sucrose complexSide EffectsCardiac Arrthymias .Drug InteractionsAs with all parenteral iron preparations, iron sucrose should not be administered concomitantly with oral iron preparations since the absorption of oral iron is reduced. Therefore, oral iron therapy should be started at least 5 days after the last injection of Iron Sucrose.IndicationIron deficiency in cases where oral iron cannot be provided . When not to UseThe use of ferric sucrose is contra-indicated in cases of: - Known hypersensitivity to iron sucrose or any of its components. - Anemias not attributable to iron deficiency. - Iron overload or disturbances in utilization of iron. - Patients with a history of asthma, eczema or other atopic allergy, because they are more susceptible to experience allergic reactions. - Pregnancy first trimester .Ferosoft-S Iv PrecautionsPrecautionParenteral administered iron preparations can cause allergic or anaphylactoid reactions, which may be potentially fatal. Therefore, treatment for serious allergic reactions and facilities with the established cardio-pulmonary resuscitation procedures should be available.Ferosoft-S Iv WarningsWarning 1In patients with liver dysfunction, parenteral iron should only be administered after careful risk/benefit assessment. Parenteral iron administration should be avoided in patients with hepatic dysfunction where iron overload is a precipitating factor, in particular Porphyria Cutanea Tarda (PCT). Careful monitoring of iron status is recommended to avoid iron overload . Warning 2Parenteral iron must be used with caution in case of acute or chronic infection. It is recommended that the administration of iron sucrose is stopped in patients with ongoing bacteremia. In patients with chronic infection a risk/benefit evaluation has to be performed, taking into account the suppression of erythropoiesis . Warning 3Hypotensive episodes may occur if the injection is administered too rapidly. Allergic reactions, sometimes involving arthralgia, have been more commonly observed when the recommended dose is exceeded . Ferosoft-S Iv Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
Ferosom Forte Caps 20'S
Description For treatment and prevention of anemia. For preventing iron, folic acid acid, vitamin B12 and zinc deficiences during pregnancy, breastfeeding, after surgery or in conditions of nutritional malabsorption.
